Literature DB >> 2634008

Prescription audit of under six children living in periurban areas.

O Prakash, G P Mathur, Y D Singh, K P Kushwaha.   

Abstract

One hundred and seventy two children were prescribed, in 212 episodes of illness, antimicrobial agents (28.4%), followed by antidiarrheals (10.9%), nutritional products (9.4%), analgesics (7.5%) and steroids (6.8%). Ampicillin (22.7%) and cotrimoxazole (12.7%) were the most commonly prescribed antimicrobials. Tetracyclines, which are not indicated in children below 8 years, were used in 7.1% of total exposures of chemotherapeutic agents. Penicillin, a comparatively safe and useful drug, was used only in 4.5% exposures. Analgin and hydroxyquinolines were used frequently. Corticosteroids were used for simple ailments like diarrhea, fever and jaundice. ORS was used in only 13.9% episodes of diarrhea. Adverse drug reactions were noted in 30 (17.4%) cases and death in 6 (3.5%) cases. The average cost per prescription for neonates was Rs 32.43 and for a child was Rs 30.65. Weight of the children was not taken prior to prescribing drugs. There is need for prescription audit as there is high consumption rate of drugs, with overuse of antimicrobial and nutritional products, and misuse of steroids.

Entities:  

Mesh:

Year:  1989        PMID: 2634008

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN: 0019-6061            Impact factor:   1.411


  3 in total

1.  Unnecessary injections and poliomyelitis.

Authors:  H V Wyatt; S Mahadevan
Journal:  Indian J Pediatr       Date:  1993 May-Jun       Impact factor: 1.967

2.  Unnecessary injections given to children under five years.

Authors:  D Ashwath; C Latha; M B Soudarssanane; H V Wyatt
Journal:  Indian J Pediatr       Date:  1993 May-Jun       Impact factor: 1.967

3.  Private pharmacy staff in Hanoi dispensing steroids - theory and practice.

Authors:  Mattias Larsson; Nguyen Thanh Binh; Göran Tomson; Nguyen Tk Chuc; Torkel Falkenberg
Journal:  Pharm Pract (Granada)       Date:  2006-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.